Dr. Reddy's Lab gains on launching Fulvestrant Injection in US market

08 Sep 2020 Evaluate

Dr. Reddys Laboratories is currently trading at Rs. 4457.00, up by 34.75 points or 0.79% from its previous closing of Rs. 4422.25 on the BSE.

The scrip opened at Rs. 4460.00 and has touched a high and low of Rs. 4481.00 and Rs. 4436.90 respectively.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 4754.30 on 10-Aug-2020 and a 52 week low of Rs. 2497.60 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 4482.00 and Rs. 4294.10 respectively. The current market cap of the company is Rs. 73522.12 crore.

The promoters holding in the company stood at 26.74%, while Institutions and Non-Institutions held 43.97% and 15.25% respectively.

Dr. Reddy's Laboratories has launched  Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe, a therapeutic equivalent generic version of Faslodex (fulvestrant) Injection, 250 mg/5 mL (50 mg/mL), approved by the U.S. Food and Drug Administration (USFDA).

The Faslodex brand and generic market had U.S. sales of around $407 million MAT for the most recent twelve months ending in June 2020 according to IQVIA Health. The company’s Fulvestrant Injection, 250 mg/5 mL (50 mg/mL) per Single-dose Syringe is available in a carton containing two 5 mL single-dose prefilled syringes.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1246.25 -20.90 (-1.65%)
09-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1776.20
Dr. Reddys Lab 1246.25
Cipla 1490.70
Zydus Lifesciences 919.90
Lupin 2052.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×